Literature DB >> 23598390

Slc7a5 helps T cells get with the program.

Jonathan D Powell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23598390     DOI： 10.1038/ni.2594

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  13 in total

1.  The CD28 signaling pathway regulates glucose metabolism.

Authors:  Kenneth A Frauwirth; James L Riley; Marian H Harris; Richard V Parry; Jeffrey C Rathmell; David R Plas; Rebecca L Elstrom; Carl H June; Craig B Thompson
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

2.  Revving the engine: signal transduction fuels T cell activation.

Authors:  Russell G Jones; Craig B Thompson
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

Review 3.  CATs and HATs: the SLC7 family of amino acid transporters.

Authors:  François Verrey; Ellen I Closs; Carsten A Wagner; Manuel Palacin; Hitoshi Endou; Yoshikatsu Kanai
Journal:  Pflugers Arch       Date:  2003-06-11       Impact factor: 3.657

4.  Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation.

Authors:  Giovanna Angelini; Stefania Gardella; Massimo Ardy; Maria Rosa Ciriolo; Giuseppe Filomeni; Giovanna Di Trapani; Frank Clarke; Roberto Sitia; Anna Rubartelli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

5.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

Review 6.  mTOR: from growth signal integration to cancer, diabetes and ageing.

Authors:  Roberto Zoncu; Alejo Efeyan; David M Sabatini
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12-15       Impact factor: 94.444

Review 7.  mTOR, metabolism, and the regulation of T-cell differentiation and function.

Authors:  Adam T Waickman; Jonathan D Powell
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

Review 8.  Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

Authors:  David H Munn; Andrew L Mellor
Journal:  Trends Immunol       Date:  2012-10-25       Impact factor: 16.687

9.  An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.

Authors:  Carson C Thoreen; Seong A Kang; Jae Won Chang; Qingsong Liu; Jianming Zhang; Yi Gao; Laurie J Reichling; Taebo Sim; David M Sabatini; Nathanael S Gray
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

10.  PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.

Authors:  David K Finlay; Ella Rosenzweig; Linda V Sinclair; Carmen Feijoo-Carnero; Jens L Hukelmann; Julia Rolf; Andrey A Panteleyev; Klaus Okkenhaug; Doreen A Cantrell
Journal:  J Exp Med       Date:  2012-11-26       Impact factor: 14.307
View more
  4 in total

1.  Cytosolic branched chain aminotransferase (BCATc) regulates mTORC1 signaling and glycolytic metabolism in CD4+ T cells.

Authors:  Elitsa A Ananieva; Chirag H Patel; Charles H Drake; Jonathan D Powell; Susan M Hutson
Journal:  J Biol Chem       Date:  2014-05-20       Impact factor: 5.157

2.  Neuronal allodynic mechanisms of Slc7a5 (LAT1) in the spared nerve injury rodent model of neuropathic pain.

Authors:  Aleyah E Goins; Kimberly Gomez; Dongzhi Ran; Mitra Afaghpour-Becklund; Rajesh Khanna; Sascha R A Alles
Journal:  Pflugers Arch       Date:  2022-01-20       Impact factor: 3.657

Review 3.  Putative roles of SLC7A5 (LAT1) transporter in pain.

Authors:  Sascha R A Alles; Kimberly Gomez; Aubin Moutal; Rajesh Khanna
Journal:  Neurobiol Pain       Date:  2020-06-30

Review 4.  T cell metabolism drives immunity.

Authors:  Michael D Buck; David O'Sullivan; Erika L Pearce
Journal:  J Exp Med       Date:  2015-08-10       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.